Case Report: The application of sildenafil citrate treatment on cervical tuberculosis patient seeking IVF treatment

This case report describes the application of sildenafil citrate treatment in a cervical tuberculosis (TB) patient seeking vitro fertilization (IVF) treatment. The patient, 34-year-old female with history TB and primary infertility, underwent anti-TB before fertility Cervical stenosis thin endometrium were identified during transvaginal ultrasound, posing challenges to successful IVF outcomes. Sildenafil citrate, phosphodiesterase-5 (PDE-5) inhibitor known improve endometrial blood flow, was administered orally at dosage 50 mg, three times daily, starting on fifth day menstrual cycle. exhibited an increase thickness, indicating improved receptivity. Clinical pregnancy achieved. These findings suggest that may have potential as adjunct therapy enhance success patients, although further research is needed validate these results larger studies.